Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,071,070
in 6 filings, $11.0M under 10b5-1 plans

Net −$11,071,070. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-24 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Option (Right to buy) +634,021 634,021
2022-02-22 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Option (Right to buy) +625,874 625,874
2021-03-04 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Options (Right to buy) +530,000 530,000
2020-02-27 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +420,000 420,000
2019-02-26 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Options (Right to Buy) +380,000 380,000
2018-02-20 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Options (Right to buy) +325,000 325,000
2017-02-23 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Option (Right to buy) +434,350 434,350
2016-06-13 Yoder Stephen S. President and CEO Purchase +6,000 $1.68 $10K 6,000
2016-02-12 Yoder Stephen S. President and CEO Grant or award · Stock Option (right to buy) +492,000 492,000

Page 1 of 1 · 9 trades